Purdue team develops implantable delivery system; National Science Foundation funds hydrogels to help treat ear disorders;

> Purdue University researchers have created an implantable drug-delivery system that can be wirelessly controlled. "This method allows a very, very small dose of a drug to effectively serve as a big dose right where you need it," Professor of Applied Neuroscience Richard Borgens said. "By the time the drug diffuses from the site out into the rest of the body it is in amounts that are undetectable in the usual tests to monitor the concentration of drugs in the bloodstream." More

> ProLynx received additional funding from the U.S. National Science Foundation to fund in vivo imaging studies of its hydrogels as a means of drug delivery for therapies that treat inner ear disorders. More

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.